Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates

Go back to Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates
Integra LifeSciences Holdings (NASDAQ: IART) Delayed: 18.34 --0 (-0%)
Previous Close $18.34    52 Week High $88.86 
Open $18.34    52 Week Low $54.75 
Day High $18.34    P/E N/A 
Day Low $18.34    EPS $-0.59 
Volume 210